Lantern Pharma, Inc. (LTRN)
3.60
-0.15
(-4.00%)
USD |
NASDAQ |
Jun 09, 12:41
Lantern Pharma Shareholders Equity (Quarterly) : 3.446M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Replimune Group, Inc. | 210.54M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Oncolytics Biotech, Inc. | -5.13M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.505B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.223M |
| Total Liabilities (Quarterly) | 3.777M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 1.868 |
| Net Debt Paydown Yield | 0.24% |